����ӰԺ

SURREY, B.C. – Ground has been broken on a new purpose-built facility in Surrey by for (ACSI), a Canadian-owned company that specializes in cyclotron manufacturing.

Located at 19145 34A Avenue in Campbell Heights, the facility will replace ACSI’s existing 24,000 square foot Richmond plant with a 48,000 square foot manufacturing space specifically designed to support the assembly, testing and development of advanced cyclotron systems used in nuclear medicine, medical isotope production and emerging cancer therapies, explains a release.

“We built ACSI into a global leader in the nuclear medicine industry from a small facility in Richmond, and this move to Surrey is the next chapter,” noted Richard Eppich, ACSI CEO, in a statement. “This facility ensures that the innovation, the jobs and the intellectual property that will support the next era of cancer diagnosis and treatment remain in Canada. We will now have the room and infrastructure to serve our customers faster and continue to compete with anyone in the world.”

ACSI currently has more than 80 systems deployed worldwide and is recognized as the fourth-largest cyclotron manufacturer globally.

The new facility includes multiple dedicated cyclotron assembly pads, engineered concrete pits and trenches, 28-foot ceilings with integrated crane systems and a dedicated BC Hydro substation capable of supporting simultaneous testing of multiple cyclotron units, the release notes. The expanded footprint will more than double ACSI’s production capacity.

Once operational, the facility is expected to support more than 120 full-time employees within five years.

“Specialized industrial facilities like this require early collaboration, careful planning and a deep understanding of the client’s operations,” emphasized Joshua Gaglardi, president of Orion Construction. “This facility has been designed around ACSI’s highly technical manufacturing needs, from the crane systems and testing infrastructure to the precision environments required for cyclotron production. Delivering a project of this complexity speaks to the strength of the partnership and the importance of building spaces that support Canadian innovation, advanced manufacturing and technologies used in cancer diagnosis and treatment around the world.”